Loading...

PE anti-mouse/human CD44 Antibody PE anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_PE_071608.jpg
C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_071608.jpg
    C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_human
    Human peripheral blood lymphocytes stained with IM7 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
103008 200 µg SEK1227
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103023 25 tests SEK370
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103007 50 µg SEK471
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103024 100 tests SEK983
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. For µg sizes, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  2. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  3. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  4. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  5. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  6. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  7. Gilazieva Z, et al. 2022. Curr Issues Mol Biol. 44:5363. PubMed
  8. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  9. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  10. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  11. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  12. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  13. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  14. Scanlon VM, et al. 2022. Sci Rep. 12:16218. PubMed
  15. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  16. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  17. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  18. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  19. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  20. Tada T, et al. 2023. JCI Insight. 8:. PubMed
  21. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  22. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  23. A R, et al. 2023. Front Oncol. 13:1147668. PubMed
  24. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  25. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  26. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  27. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  28. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  29. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  30. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  31. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  32. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  33. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  34. Hammer A, et al. 2017. J Neuroinflammation. 10.1186/s12974-017-0954-y. PubMed
  35. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  36. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  37. Saenz F, et al. 2014. PLoS One. 9:97666. PubMed
  38. Wang D, et al. 2018. Immunity. 48:659. PubMed
  39. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  40. Yang C, et al. 2022. Cancers (Basel). 14:. PubMed
  41. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  42. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  43. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  44. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  45. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  46. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  47. Davila S, et al. 2014. J Immunol. 192:4284. PubMed
  48. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  49. Trial J, et al. 2017. Basic Research in Cardiology. 10.1007/s00395-017-0623-4. PubMed
  50. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  51. Shao B, et al. 2019. J Immunol. 10.4049/jimmunol.1900680. PubMed
  52. Sung SE, et al. 2021. Vet Sci. 8:. PubMed
  53. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  54. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  55. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  56. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  57. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  58. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  59. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  60. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  61. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  62. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  63. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  64. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  65. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  66. Shao W, et al. 2010. Transplant Proc. 42:2777. PubMed
  67. Tyne A, et al. 2013. Vaccine. 31:4322. PubMed
  68. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  69. Chulpanova DS, et al. 2020. Bioengineering (Basel). 7:00. PubMed
  70. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  71. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  72. Du L et al. 2019. Cell metabolism. 29(6):1363-1375 . PubMed
  73. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  74. Li P, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.24. PubMed
  75. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  76. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  77. Hammer A, et al. 2016. Proc Natl Acad Sci U S A. 113(49):14109-14114. PubMed
  78. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  79. Chen Y, et al. 2010. Mol Cancer Ther. 2.374305556. PubMed
  80. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  81. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  82. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  83. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  84. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  85. Kong T, et al. 2020. Cancer Res. 80:444. PubMed
  86. Blacking T, et al. 2011. Vet Immunol Immunopathol. 141:46. PubMed
  87. Sentman A 2011. Blood. 117:6571. PubMed
  88. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  89. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  90. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  91. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  92. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  93. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  94. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  95. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  96. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  97. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  98. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  99. Li P, et al. 2018. J Cell Mol Med. 22:3423. PubMed
  100. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  101. Zhang Z, et al. 2019. Cell Death Dis. 10:530. PubMed
  102. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  103. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  104. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  105. Tsuchihashi K, et al. 2022. Biochem Biophys Rep. 30:101246. PubMed
  106. Sottnik JL, et al. 2021. Cancer Res. 81:2833. PubMed
  107. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  108. Bian X, et al. 2021. Clin Transl Med. 11:e352. PubMed
  109. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  110. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  111. Ge C, et al. 2020. Cell Reports. 29(13):4236-4244.e3.. PubMed
  112. Yip HYK, et al. 2018. PLoS One. 3. PubMed
  113. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  114. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  115. Ngamsri KC, et al. 2022. Cells. 11:. PubMed
  116. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  117. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  118. Melhem H, et al. 2022. Mucosal Immunol. 15:443. PubMed
  119. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  120. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  121. Wang S, et al. 2021. Parasite. 28:13. PubMed
  122. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  123. Xu Y, et al. 2020. Stem Cells Int. 8894449:2020. PubMed
  124. Fiume G, et al. 2015. Sci Rep. 5: 13864. PubMed
  125. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  126. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  127. Morley S, et al. 2008. J Immunol. 181:4696. PubMed
  128. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  129. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  130. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  131. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  132. Yermanos A, et al. 2020. Front Immunol. 1.143055556. PubMed
  133. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  134. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  135. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  136. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  137. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  138. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  139. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  140. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  141. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  142. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  143. Girón-Pérez DA, et al. 2020. J Cell Sci. 133:00:00. PubMed
  144. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  145. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  146. Lu H, et al. 2019. EBioMedicine. 40:276. PubMed
  147. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  148. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  149. Korin B, et al. 2020. Sleep. :43. PubMed
  150. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  151. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  152. Kaji T, et al. 2016. Int Immunol. 28: 267 - 282. PubMed
  153. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  154. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  155. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  156. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  157. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  158. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  159. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  160. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  161. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  162. Seo MS, et al. 2021. Vet Sci. 8:. PubMed
  163. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  164. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  165. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  166. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
  167. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  168. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
  169. Velletri T, et al. 2020. Cell Death Differ. . PubMed
  170. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  171. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  172. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  173. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  174. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  175. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  176. Gilazieva Z, et al. 2022. Curr Issues Mol Biol. 44:5363. PubMed
  177. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  178. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  179. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  180. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  181. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  182. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  183. Scanlon VM, et al. 2022. Sci Rep. 12:16218. PubMed
  184. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  185. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  186. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  187. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  188. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  189. Tada T, et al. 2023. JCI Insight. 8:. PubMed
  190. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  191. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  192. A R, et al. 2023. Front Oncol. 13:1147668. PubMed
  193. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  194. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  195. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  196. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  197. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  198. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  199. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  200. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  201. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  202. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  203. Hammer A, et al. 2017. J Neuroinflammation. 10.1186/s12974-017-0954-y. PubMed
  204. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  205. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  206. Saenz F, et al. 2014. PLoS One. 9:97666. PubMed
  207. Wang D, et al. 2018. Immunity. 48:659. PubMed
  208. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  209. Yang C, et al. 2022. Cancers (Basel). 14:. PubMed
  210. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  211. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  212. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  213. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  214. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  215. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  216. Davila S, et al. 2014. J Immunol. 192:4284. PubMed
  217. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  218. Trial J, et al. 2017. Basic Research in Cardiology. 10.1007/s00395-017-0623-4. PubMed
  219. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  220. Shao B, et al. 2019. J Immunol. 10.4049/jimmunol.1900680. PubMed
  221. Sung SE, et al. 2021. Vet Sci. 8:. PubMed
  222. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  223. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  224. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  225. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  226. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  227. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  228. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  229. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  230. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  231. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  232. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  233. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  234. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  235. Shao W, et al. 2010. Transplant Proc. 42:2777. PubMed
  236. Tyne A, et al. 2013. Vaccine. 31:4322. PubMed
  237. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  238. Chulpanova DS, et al. 2020. Bioengineering (Basel). 7:00. PubMed
  239. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  240. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  241. Du L et al. 2019. Cell metabolism. 29(6):1363-1375 . PubMed
  242. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  243. Li P, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.24. PubMed
  244. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  245. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  246. Hammer A, et al. 2016. Proc Natl Acad Sci U S A. 113(49):14109-14114. PubMed
  247. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  248. Chen Y, et al. 2010. Mol Cancer Ther. 2.374305556. PubMed
  249. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  250. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  251. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  252. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  253. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  254. Kong T, et al. 2020. Cancer Res. 80:444. PubMed
  255. Blacking T, et al. 2011. Vet Immunol Immunopathol. 141:46. PubMed
  256. Sentman A 2011. Blood. 117:6571. PubMed
  257. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  258. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  259. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  260. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  261. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  262. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  263. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  264. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  265. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  266. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  267. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  268. Li P, et al. 2018. J Cell Mol Med. 22:3423. PubMed
  269. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  270. Zhang Z, et al. 2019. Cell Death Dis. 10:530. PubMed
  271. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  272. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  273. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  274. Tsuchihashi K, et al. 2022. Biochem Biophys Rep. 30:101246. PubMed
  275. Sottnik JL, et al. 2021. Cancer Res. 81:2833. PubMed
  276. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  277. Bian X, et al. 2021. Clin Transl Med. 11:e352. PubMed
  278. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  279. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  280. Ge C, et al. 2020. Cell Reports. 29(13):4236-4244.e3.. PubMed
  281. Yip HYK, et al. 2018. PLoS One. 3. PubMed
  282. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  283. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  284. Ngamsri KC, et al. 2022. Cells. 11:. PubMed
  285. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  286. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  287. Melhem H, et al. 2022. Mucosal Immunol. 15:443. PubMed
  288. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  289. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  290. Wang S, et al. 2021. Parasite. 28:13. PubMed
  291. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  292. Xu Y, et al. 2020. Stem Cells Int. 8894449:2020. PubMed
  293. Fiume G, et al. 2015. Sci Rep. 5: 13864. PubMed
  294. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  295. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  296. Morley S, et al. 2008. J Immunol. 181:4696. PubMed
  297. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  298. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  299. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  300. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  301. Yermanos A, et al. 2020. Front Immunol. 1.143055556. PubMed
  302. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  303. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  304. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  305. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  306. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  307. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  308. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  309. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  310. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  311. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  312. Girón-Pérez DA, et al. 2020. J Cell Sci. 133:00:00. PubMed
  313. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  314. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  315. Lu H, et al. 2019. EBioMedicine. 40:276. PubMed
  316. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  317. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  318. Korin B, et al. 2020. Sleep. :43. PubMed
  319. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  320. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  321. Kaji T, et al. 2016. Int Immunol. 28: 267 - 282. PubMed
  322. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  323. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  324. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  325. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  326. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  327. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  328. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  329. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  330. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  331. Seo MS, et al. 2021. Vet Sci. 8:. PubMed
  332. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  333. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  334. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  335. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
  336. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  337. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
  338. Velletri T, et al. 2020. Cell Death Differ. . PubMed
RRID
AB_312959 (BioLegend Cat. No. 103008)
AB_493686 (BioLegend Cat. No. 103023)
AB_312958 (BioLegend Cat. No. 103007)
AB_493687 (BioLegend Cat. No. 103024)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
APC anti-mouse/human CD44 IM7 FC
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark YG™ 581 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark NIR™ 685 anti-mouse/human CD44 (Flexi-Fluor™) Antibody IM7 FC
Spark UV™ 387 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
StarBright UltraViolet 795 anti-mouse/human CD44 IM7 FC
Go To Top Version: 4    Revision Date: 10-15-2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_PE_071608.jpg
C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_071608.jpg
    C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_human
    Human peripheral blood lymphocytes stained with IM7 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
103008 200 µg SEK1227
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103023 25 tests SEK370
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103007 50 µg SEK471
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103024 100 tests SEK983
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. For µg sizes, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  2. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  3. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  4. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  5. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  6. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  7. Gilazieva Z, et al. 2022. Curr Issues Mol Biol. 44:5363. PubMed
  8. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  9. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  10. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  11. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  12. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  13. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  14. Scanlon VM, et al. 2022. Sci Rep. 12:16218. PubMed
  15. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  16. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  17. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  18. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  19. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  20. Tada T, et al. 2023. JCI Insight. 8:. PubMed
  21. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  22. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  23. A R, et al. 2023. Front Oncol. 13:1147668. PubMed
  24. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  25. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  26. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  27. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  28. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  29. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  30. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  31. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  32. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  33. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  34. Hammer A, et al. 2017. J Neuroinflammation. 10.1186/s12974-017-0954-y. PubMed
  35. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  36. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  37. Saenz F, et al. 2014. PLoS One. 9:97666. PubMed
  38. Wang D, et al. 2018. Immunity. 48:659. PubMed
  39. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  40. Yang C, et al. 2022. Cancers (Basel). 14:. PubMed
  41. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  42. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  43. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  44. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  45. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  46. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  47. Davila S, et al. 2014. J Immunol. 192:4284. PubMed
  48. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  49. Trial J, et al. 2017. Basic Research in Cardiology. 10.1007/s00395-017-0623-4. PubMed
  50. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  51. Shao B, et al. 2019. J Immunol. 10.4049/jimmunol.1900680. PubMed
  52. Sung SE, et al. 2021. Vet Sci. 8:. PubMed
  53. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  54. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  55. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  56. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  57. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  58. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  59. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  60. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  61. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  62. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  63. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  64. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  65. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  66. Shao W, et al. 2010. Transplant Proc. 42:2777. PubMed
  67. Tyne A, et al. 2013. Vaccine. 31:4322. PubMed
  68. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  69. Chulpanova DS, et al. 2020. Bioengineering (Basel). 7:00. PubMed
  70. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  71. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  72. Du L et al. 2019. Cell metabolism. 29(6):1363-1375 . PubMed
  73. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  74. Li P, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.24. PubMed
  75. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  76. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  77. Hammer A, et al. 2016. Proc Natl Acad Sci U S A. 113(49):14109-14114. PubMed
  78. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  79. Chen Y, et al. 2010. Mol Cancer Ther. 2.374305556. PubMed
  80. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  81. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  82. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  83. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  84. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  85. Kong T, et al. 2020. Cancer Res. 80:444. PubMed
  86. Blacking T, et al. 2011. Vet Immunol Immunopathol. 141:46. PubMed
  87. Sentman A 2011. Blood. 117:6571. PubMed
  88. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  89. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  90. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  91. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  92. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  93. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  94. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  95. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  96. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  97. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  98. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  99. Li P, et al. 2018. J Cell Mol Med. 22:3423. PubMed
  100. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  101. Zhang Z, et al. 2019. Cell Death Dis. 10:530. PubMed
  102. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  103. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  104. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  105. Tsuchihashi K, et al. 2022. Biochem Biophys Rep. 30:101246. PubMed
  106. Sottnik JL, et al. 2021. Cancer Res. 81:2833. PubMed
  107. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  108. Bian X, et al. 2021. Clin Transl Med. 11:e352. PubMed
  109. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  110. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  111. Ge C, et al. 2020. Cell Reports. 29(13):4236-4244.e3.. PubMed
  112. Yip HYK, et al. 2018. PLoS One. 3. PubMed
  113. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  114. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  115. Ngamsri KC, et al. 2022. Cells. 11:. PubMed
  116. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  117. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  118. Melhem H, et al. 2022. Mucosal Immunol. 15:443. PubMed
  119. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  120. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  121. Wang S, et al. 2021. Parasite. 28:13. PubMed
  122. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  123. Xu Y, et al. 2020. Stem Cells Int. 8894449:2020. PubMed
  124. Fiume G, et al. 2015. Sci Rep. 5: 13864. PubMed
  125. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  126. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  127. Morley S, et al. 2008. J Immunol. 181:4696. PubMed
  128. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  129. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  130. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  131. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  132. Yermanos A, et al. 2020. Front Immunol. 1.143055556. PubMed
  133. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  134. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  135. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  136. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  137. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  138. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  139. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  140. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  141. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  142. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  143. Girón-Pérez DA, et al. 2020. J Cell Sci. 133:00:00. PubMed
  144. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  145. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  146. Lu H, et al. 2019. EBioMedicine. 40:276. PubMed
  147. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  148. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  149. Korin B, et al. 2020. Sleep. :43. PubMed
  150. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  151. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  152. Kaji T, et al. 2016. Int Immunol. 28: 267 - 282. PubMed
  153. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  154. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  155. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  156. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  157. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  158. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  159. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  160. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  161. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  162. Seo MS, et al. 2021. Vet Sci. 8:. PubMed
  163. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  164. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  165. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  166. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
  167. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  168. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
  169. Velletri T, et al. 2020. Cell Death Differ. . PubMed
  170. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  171. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  172. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  173. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  174. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  175. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  176. Gilazieva Z, et al. 2022. Curr Issues Mol Biol. 44:5363. PubMed
  177. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  178. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  179. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  180. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  181. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  182. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  183. Scanlon VM, et al. 2022. Sci Rep. 12:16218. PubMed
  184. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  185. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  186. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  187. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  188. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  189. Tada T, et al. 2023. JCI Insight. 8:. PubMed
  190. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  191. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  192. A R, et al. 2023. Front Oncol. 13:1147668. PubMed
  193. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  194. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  195. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  196. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  197. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  198. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  199. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  200. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  201. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  202. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  203. Hammer A, et al. 2017. J Neuroinflammation. 10.1186/s12974-017-0954-y. PubMed
  204. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  205. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  206. Saenz F, et al. 2014. PLoS One. 9:97666. PubMed
  207. Wang D, et al. 2018. Immunity. 48:659. PubMed
  208. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  209. Yang C, et al. 2022. Cancers (Basel). 14:. PubMed
  210. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  211. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  212. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  213. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  214. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  215. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  216. Davila S, et al. 2014. J Immunol. 192:4284. PubMed
  217. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  218. Trial J, et al. 2017. Basic Research in Cardiology. 10.1007/s00395-017-0623-4. PubMed
  219. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  220. Shao B, et al. 2019. J Immunol. 10.4049/jimmunol.1900680. PubMed
  221. Sung SE, et al. 2021. Vet Sci. 8:. PubMed
  222. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  223. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  224. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  225. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  226. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  227. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  228. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  229. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  230. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  231. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  232. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  233. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  234. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  235. Shao W, et al. 2010. Transplant Proc. 42:2777. PubMed
  236. Tyne A, et al. 2013. Vaccine. 31:4322. PubMed
  237. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  238. Chulpanova DS, et al. 2020. Bioengineering (Basel). 7:00. PubMed
  239. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  240. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  241. Du L et al. 2019. Cell metabolism. 29(6):1363-1375 . PubMed
  242. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  243. Li P, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.24. PubMed
  244. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  245. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  246. Hammer A, et al. 2016. Proc Natl Acad Sci U S A. 113(49):14109-14114. PubMed
  247. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  248. Chen Y, et al. 2010. Mol Cancer Ther. 2.374305556. PubMed
  249. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  250. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  251. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  252. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  253. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  254. Kong T, et al. 2020. Cancer Res. 80:444. PubMed
  255. Blacking T, et al. 2011. Vet Immunol Immunopathol. 141:46. PubMed
  256. Sentman A 2011. Blood. 117:6571. PubMed
  257. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  258. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  259. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  260. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  261. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  262. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  263. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  264. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  265. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  266. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  267. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  268. Li P, et al. 2018. J Cell Mol Med. 22:3423. PubMed
  269. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  270. Zhang Z, et al. 2019. Cell Death Dis. 10:530. PubMed
  271. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  272. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  273. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  274. Tsuchihashi K, et al. 2022. Biochem Biophys Rep. 30:101246. PubMed
  275. Sottnik JL, et al. 2021. Cancer Res. 81:2833. PubMed
  276. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  277. Bian X, et al. 2021. Clin Transl Med. 11:e352. PubMed
  278. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  279. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  280. Ge C, et al. 2020. Cell Reports. 29(13):4236-4244.e3.. PubMed
  281. Yip HYK, et al. 2018. PLoS One. 3. PubMed
  282. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  283. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  284. Ngamsri KC, et al. 2022. Cells. 11:. PubMed
  285. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  286. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  287. Melhem H, et al. 2022. Mucosal Immunol. 15:443. PubMed
  288. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  289. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  290. Wang S, et al. 2021. Parasite. 28:13. PubMed
  291. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  292. Xu Y, et al. 2020. Stem Cells Int. 8894449:2020. PubMed
  293. Fiume G, et al. 2015. Sci Rep. 5: 13864. PubMed
  294. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  295. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  296. Morley S, et al. 2008. J Immunol. 181:4696. PubMed
  297. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  298. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  299. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  300. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  301. Yermanos A, et al. 2020. Front Immunol. 1.143055556. PubMed
  302. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  303. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  304. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  305. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  306. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  307. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  308. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  309. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  310. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  311. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  312. Girón-Pérez DA, et al. 2020. J Cell Sci. 133:00:00. PubMed
  313. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  314. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  315. Lu H, et al. 2019. EBioMedicine. 40:276. PubMed
  316. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  317. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  318. Korin B, et al. 2020. Sleep. :43. PubMed
  319. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  320. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  321. Kaji T, et al. 2016. Int Immunol. 28: 267 - 282. PubMed
  322. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  323. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  324. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  325. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  326. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  327. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  328. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  329. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  330. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  331. Seo MS, et al. 2021. Vet Sci. 8:. PubMed
  332. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  333. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  334. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  335. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
  336. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  337. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
  338. Velletri T, et al. 2020. Cell Death Differ. . PubMed
RRID
AB_312959 (BioLegend Cat. No. 103008)
AB_493686 (BioLegend Cat. No. 103023)
AB_312958 (BioLegend Cat. No. 103007)
AB_493687 (BioLegend Cat. No. 103024)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
APC anti-mouse/human CD44 IM7 FC
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark YG™ 581 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark NIR™ 685 anti-mouse/human CD44 (Flexi-Fluor™) Antibody IM7 FC
Spark UV™ 387 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
StarBright UltraViolet 795 anti-mouse/human CD44 IM7 FC
Go To Top Version: 4    Revision Date: 10-15-2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account